OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease
Alain Lescoat, M Lelong, Mohamed Jeljeli, et al.
Biochemical Pharmacology (2020) Vol. 178, pp. 114103-114103
Open Access | Times Cited: 120
Alain Lescoat, M Lelong, Mohamed Jeljeli, et al.
Biochemical Pharmacology (2020) Vol. 178, pp. 114103-114103
Open Access | Times Cited: 120
Showing 1-25 of 120 citing articles:
Targeting fibrosis: mechanisms and clinical trials
Manyu Zhao, Liqun Wang, Mengzhu Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 239
Manyu Zhao, Liqun Wang, Mengzhu Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 239
Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms
Paula Montero, Javier Milara, Inés Roger, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6211-6211
Open Access | Times Cited: 178
Paula Montero, Javier Milara, Inés Roger, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6211-6211
Open Access | Times Cited: 178
Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis
Joe‐Elie Salem, Marie Bretagne, Baptiste Abbar, et al.
Cancer Discovery (2023) Vol. 13, Iss. 5, pp. 1100-1115
Open Access | Times Cited: 111
Joe‐Elie Salem, Marie Bretagne, Baptiste Abbar, et al.
Cancer Discovery (2023) Vol. 13, Iss. 5, pp. 1100-1115
Open Access | Times Cited: 111
New insights into fibrosis from the ECM degradation perspective: the macrophage-MMP-ECM interaction
Xiangyu Zhao, Jiayin Chen, Hongxiang Sun, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 88
Xiangyu Zhao, Jiayin Chen, Hongxiang Sun, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 88
Regulatory Mechanism of M1/M2 Macrophage Polarization in the Development of Autoimmune Diseases
Yuan Peng, Mengxian Zhou, Yang Hong, et al.
Mediators of Inflammation (2023) Vol. 2023, pp. 1-20
Open Access | Times Cited: 59
Yuan Peng, Mengxian Zhou, Yang Hong, et al.
Mediators of Inflammation (2023) Vol. 2023, pp. 1-20
Open Access | Times Cited: 59
Mesenchymal stem cell exosomal tsRNA-21109 alleviate systemic lupus erythematosus by inhibiting macrophage M1 polarization
Rui Dou, Xiulei Zhang, Xiangdong Xu, et al.
Molecular Immunology (2021) Vol. 139, pp. 106-114
Closed Access | Times Cited: 85
Rui Dou, Xiulei Zhang, Xiangdong Xu, et al.
Molecular Immunology (2021) Vol. 139, pp. 106-114
Closed Access | Times Cited: 85
A retrospective study of the efficacy of JAK inhibitors or abatacept on rheumatoid arthritis-interstitial lung disease
Marika Tardella, Marco Di Carlo, Marina Carotti, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 3, pp. 705-712
Open Access | Times Cited: 58
Marika Tardella, Marco Di Carlo, Marina Carotti, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 3, pp. 705-712
Open Access | Times Cited: 58
The ACE2-Ang-(1‑7)-Mas Axis Modulates M1/M2 Macrophage Polarization to Relieve CLP-Induced Inflammation via TLR4-Mediated NF-кb and MAPK Pathways
Hang Pan, Wenhan Huang, Zhongjie Wang, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 2045-2060
Open Access | Times Cited: 57
Hang Pan, Wenhan Huang, Zhongjie Wang, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 2045-2060
Open Access | Times Cited: 57
An update on targeted therapies in systemic sclerosis based on a systematic review from the last 3 years
Corrado Campochiaro, Yannick Allanore
Arthritis Research & Therapy (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 57
Corrado Campochiaro, Yannick Allanore
Arthritis Research & Therapy (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 57
Contribution of monocytes and macrophages to the pathogenesis of systemic sclerosis: recent insights and therapeutic implications
Alain Lescoat, Valérie Lecureur, John Varga
Current Opinion in Rheumatology (2021) Vol. 33, Iss. 6, pp. 463-470
Closed Access | Times Cited: 57
Alain Lescoat, Valérie Lecureur, John Varga
Current Opinion in Rheumatology (2021) Vol. 33, Iss. 6, pp. 463-470
Closed Access | Times Cited: 57
Tofacitinib blocks IFN-regulated biomarker genes in skin fibroblasts and keratinocytes in a systemic sclerosis trial
Dinesh Khanna, Cristina M. Padilla, Lam C. Tsoi, et al.
JCI Insight (2022) Vol. 7, Iss. 17
Open Access | Times Cited: 40
Dinesh Khanna, Cristina M. Padilla, Lam C. Tsoi, et al.
JCI Insight (2022) Vol. 7, Iss. 17
Open Access | Times Cited: 40
JAK inhibitors and systemic sclerosis: A systematic review of the literature
Clothilde Moriana, T. Moulinet, R. Jaussaud, et al.
Autoimmunity Reviews (2022) Vol. 21, Iss. 10, pp. 103168-103168
Open Access | Times Cited: 39
Clothilde Moriana, T. Moulinet, R. Jaussaud, et al.
Autoimmunity Reviews (2022) Vol. 21, Iss. 10, pp. 103168-103168
Open Access | Times Cited: 39
Paeonol protects against doxorubicin-induced cardiotoxicity by promoting Mfn2-mediated mitochondrial fusion through activating the PKCε-Stat3 pathway
Mingge Ding, Rui Shi, Feng Fu, et al.
Journal of Advanced Research (2022) Vol. 47, pp. 151-162
Open Access | Times Cited: 38
Mingge Ding, Rui Shi, Feng Fu, et al.
Journal of Advanced Research (2022) Vol. 47, pp. 151-162
Open Access | Times Cited: 38
The macrophage polarization in inflammatory dermatosis and its potential drug candidates
Qingru Sun, Shiyu Hu, Zhaohuan Lou, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114469-114469
Open Access | Times Cited: 32
Qingru Sun, Shiyu Hu, Zhaohuan Lou, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114469-114469
Open Access | Times Cited: 32
Understanding Interstitial Lung Diseases Associated with Connective Tissue Disease (CTD-ILD): Genetics, Cellular Pathophysiology, and Biologic Drivers
Giuliana Cerro Chiang, Tanyalak Parimon
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2405-2405
Open Access | Times Cited: 31
Giuliana Cerro Chiang, Tanyalak Parimon
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2405-2405
Open Access | Times Cited: 31
The role of macrophage polarization and cellular crosstalk in the pulmonary fibrotic microenvironment: a review
Bowen Zhou, Huaman Liu, Fei Xu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Bowen Zhou, Huaman Liu, Fei Xu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Emerging diagnostic and therapeutic challenges for skin fibrosis in systemic sclerosis
David Abraham, Alain Lescoat, Richard Stratton
Molecular Aspects of Medicine (2024) Vol. 96, pp. 101252-101252
Open Access | Times Cited: 11
David Abraham, Alain Lescoat, Richard Stratton
Molecular Aspects of Medicine (2024) Vol. 96, pp. 101252-101252
Open Access | Times Cited: 11
Pirfenidone ameliorates pulmonary inflammation and fibrosis in a rat silicosis model by inhibiting macrophage polarization and JAK2/STAT3 signaling pathways
Qiong Tang, Xing Chen, Ming Li, et al.
Ecotoxicology and Environmental Safety (2022) Vol. 244, pp. 114066-114066
Open Access | Times Cited: 36
Qiong Tang, Xing Chen, Ming Li, et al.
Ecotoxicology and Environmental Safety (2022) Vol. 244, pp. 114066-114066
Open Access | Times Cited: 36
Janus kinase inhibitors for treatment of morphea and systemic sclerosis: A literature review
Scott A. McGaugh, Penelope Kallis, Anna De Benedetto, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 6
Closed Access | Times Cited: 34
Scott A. McGaugh, Penelope Kallis, Anna De Benedetto, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 6
Closed Access | Times Cited: 34
Immune Checkpoint Inhibitor Myocarditis Treatment Strategies and Future Directions
Javid J. Moslehi, Joe‐Elie Salem
JACC CardioOncology (2022) Vol. 4, Iss. 5, pp. 704-707
Open Access | Times Cited: 29
Javid J. Moslehi, Joe‐Elie Salem
JACC CardioOncology (2022) Vol. 4, Iss. 5, pp. 704-707
Open Access | Times Cited: 29
Tofacitinib Promotes Functional Recovery after Spinal Cord Injury by Regulating Microglial Polarization via JAK/STAT Signaling Pathway
Hongdao Ma, Chenfeng Wang, Lin Han, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 15, pp. 4865-4882
Open Access | Times Cited: 20
Hongdao Ma, Chenfeng Wang, Lin Han, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 15, pp. 4865-4882
Open Access | Times Cited: 20
M2 macrophage polarization in systemic sclerosis fibrosis: pathogenic mechanisms and therapeutic effects
Mingyue Hu, Zhongliu Yao, Lili Xu, et al.
Heliyon (2023) Vol. 9, Iss. 5, pp. e16206-e16206
Open Access | Times Cited: 17
Mingyue Hu, Zhongliu Yao, Lili Xu, et al.
Heliyon (2023) Vol. 9, Iss. 5, pp. e16206-e16206
Open Access | Times Cited: 17
NETosis promotes chronic inflammation and fibrosis in systemic lupus erythematosus and COVID-19
Huiqing Lin, Jiejie Liu, Ning Li, et al.
Clinical Immunology (2023) Vol. 254, pp. 109687-109687
Open Access | Times Cited: 17
Huiqing Lin, Jiejie Liu, Ning Li, et al.
Clinical Immunology (2023) Vol. 254, pp. 109687-109687
Open Access | Times Cited: 17
Insight into Janus kinases specificity: From molecular architecture to cancer therapeutics
Tian‐Hua Wei, Meng‐Yi Lu, Sihui Yao, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 7
Tian‐Hua Wei, Meng‐Yi Lu, Sihui Yao, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 7
Interrelation of adipose tissue macrophages and fibrosis in obesity
Norma Dahdah, Carmen Tercero‐Alcázar, Marı́a M. Malagón, et al.
Biochemical Pharmacology (2024) Vol. 225, pp. 116324-116324
Open Access | Times Cited: 7
Norma Dahdah, Carmen Tercero‐Alcázar, Marı́a M. Malagón, et al.
Biochemical Pharmacology (2024) Vol. 225, pp. 116324-116324
Open Access | Times Cited: 7
